share_log

Autolus Therapeutics | 6-K/A: Report of foreign private issuer [Rules 13a-16 and 15d-16] (Amendment)

SEC announcement ·  Jul 6, 2023 17:38
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more